EEG Biomarkers for Opioid Use Disorder Study
This study is looking for ways to better understand Opioid Use Disorder (OUD) by studying brain activity. Researchers will use an electroencephalogram (EEG), which measures electrical activity in your brain, to look for specific patterns (biomarkers) that might help diagnose OUD, predict how it will progress, or show if treatments are working. The study is open to people aged 22 to 85 who have been diagnosed with OUD for at least six months and still experience cravings, as well as people without OUD. The goal is to enroll 70 participants to help find better ways to fight opioid addiction.
- Study design
- This is an observational study, meaning researchers will observe participants without providing any specific interventions. The study plans to enroll 70 participants, including 50 with OUD and 20 without OUD.
- What's involved
- You would undergo an electroencephalogram (EEG) test, which measures brain activity. The study procedures and equipment will be explained to you in detail.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your brain activity will be measured at 1 week.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
EEG Biomarkers for OUD: Diagnostic, Prognostic, and Predictive Applications
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Electroencephalogram power in Delta through Gamma bands1 week
High-density electroencephalogram power will be assessed during rest (eyes open, eyes closed) and activity